| Name | Title | Contact Details |
|---|
Christian Health Care Center (CHCC) has been fostering health, healing and wellness in northern New Jersey for more than 100 years. Since its inception, CHCC has grown to offer the most complete continuum of senior living, elder-care, short-term rehabilitation, and mental-health services available on any campus in the area, and serves as a vital source of services and information for clients, residents, patients, consumers, and their sponsors. Our commitment to caring begins with recognizing the intrinsic value of all individuals and helping each person reach his or her highest potential for health, healing, and wellness. In so doing, we seek not only to meet each person`s physical needs, but also to nurture emotional and spiritual well-being. Situated on 78 acres overlooking the Ramapo Mountains, CHCC is a non-profit organization that serves all people, regardless of race, sex, or religion. CHCC has expanded to meet the changing needs of the community and continues to offer care in a compassionate and loving environment consistent with the Christian values upon which we were founded. Senior Life Services include: Independent living (Wyckoff and Wayne), Supportive senior living, Adult day services (Wyckoff and Wayne), Assisted living Memory support, Skilled nursing, Behavior management. Short-term Rehabilitation: Post-acute care including rehabilitation therapy and skilled nursing. Mental-Health Services include: Inpatient psychiatric hospital, Short-term partial-hospitalization program, Outpatient counseling for people of all ages. The Vista: An independent-living community for active adults age 62 and over.
Northside Anesthesiology Consultants is a Roswell, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sensely`s avatar and chatbot-based platforms assist insurance plan members and patients with the insurance services and healthcare resources they need, when they need it.
AcelRx Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. The Company`s product candidates, DSUVIA™ (known as ARX-04 outside of the United States) and ZALVISO®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. DSUVIA is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. The Phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. In clinical studies, DSUVIA demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and vomiting. A New Drug Application (NDA) was filed with the FDA in December 2016. ZALVISO is designed to deliver sublingual tablets containing 15 mcg sufentanil via a novel hand-held, pre-programmed, patient-controlled analgesia system. Three Phase 3 clinical trials have been completed in patients who had undergone major abdominal or orthopedic surgeries. A fourth study (IAP312) is underway to further evaluate the overall performance of the ZALVISO System in post-surgical patients. ZALVISO is currently approved by the European Commission for the management of acute moderate-to-severe post-operative pain in adult patients in a hospital setting, and is marketed by Grünenthal Group, AcelRx`s licensee in Europe and Australia. In the United States and other geographies, ZALVISO remains an investigational product.
Benefit and Risk Management Services is a Folsom, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.